AMALGAMATED BANK - MONTE ROSA THERAPEUTICS INC ownership

MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of MONTE ROSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15
-28.6%
3,0290.0%0.00%
Q2 2023$21
-12.5%
3,0290.0%0.00%
Q1 2023$24
-14.3%
3,029
-16.6%
0.00%
Q4 2022$28
-99.9%
3,6310.0%0.00%
Q3 2022$30,000
-14.3%
3,6310.0%0.00%
Q2 2022$35,000
-12.5%
3,631
+28.2%
0.00%
Q1 2022$40,0002,8320.00%
Other shareholders
MONTE ROSA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,472,331$12,029,0007.99%
NEA Management Company, LLC 7,703,205$62,935,0003.14%
Cormorant Asset Management, LP 2,993,717$24,459,0001.71%
Alphabet Inc. 1,464,015$11,961,0000.61%
Avoro Capital Advisors LLC 3,363,333$27,478,0000.51%
Casdin Capital, LLC 510,882$4,174,0000.27%
RTW INVESTMENTS, LP 1,214,572$9,923,0000.23%
Woodline Partners LP 502,411$4,105,0000.06%
Virtus Investment Advisers, Inc. 12,638$103,0000.05%
CORNERCAP INVESTMENT COUNSEL INC 28,192$230,0000.04%
View complete list of MONTE ROSA THERAPEUTICS INC shareholders